Contact this trialFirst, we need to learn more about you.
Anti-metabolites
Chemotherapy +/− FUDR/Dexamethasone Pump for Bile Duct Cancer
Recruiting1 awardPhase 2
New York, New York
This trial will compare a new combination therapy to standard chemotherapy in people with inoperable cholangiocarcinoma. The goal is to see if the new therapy extends life by at least 3 months on average.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.